LOWELL, Mass., Oct. 11, 2016 -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the addition of Ed Ognibene as Vice President of Product Development. Ed will report directly to the CEO, Robert Spignesi.
Mr. Ognibene brings over 20 years of technology and product development experience with sophisticated scientific instrumentation. Most recently, he held the position of Director of Engineering / Systems Development at Waters Corporation in the Separation Systems division, where he successfully managed the R&D and Engineering teams from the acquisition of Thar Instruments, Inc., as well as the integration of these groups into the broader corporate development organization. Concurrently, Mr. Ognibene oversaw a major development program to replace a product line with innovative new systems. Prior to this, he was responsible for driving the development of novel industry leading chromatographic platform systems. Before Waters, Mr. Ognibene worked at SatCon Technologies, a MIT start-up, where he managed the Mechanical Engineering Group and was also responsible for Program Management and technology/business development.
“I am thrilled to welcome an executive of Ed’s caliber and experience to our team,” said CEO Robert Spignesi. “His track record of leading innovative technology, product development programs, and organizations will be instrumental to our continued growth and success.”
“I am pleased to step into the VP of Product Development role and take on this assignment during an exciting phase of the company’s growth,” said Mr. Ognibene. “I look forward to ensuring that our customers experience the most innovative products as they implement Rapid Micro Biosystems’ technologies throughout their organizations.”
Ed holds a PhD and MS in Mechanical Engineering from MIT and a BSME from SUNY Stony Brook. Ed is a member of ASME, Tau Beta Pi, and Sigma Xi honor societies.
About Rapid Micro Biosystems
Rapid Micro Biosystems delivers the Growth Direct™ System, an automated, non-destructive rapid detection and enumeration technology based on the compendial method for microbial quality control in pharmaceutical manufacturing. The system automates and accelerates detection and enumeration in the areas of sterility testing, environmental monitoring, and bioburden testing, eliminating manual steps and analysis. The detection technology uses the natural auto-fluorescence of microbes and requires no reagents. For more information about Rapid Micro Biosystems visit www.rapidmicrobio.com
Contact: Eugenia Kendrick Rapid Micro Biosystems [email protected]


HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Shell M&A Chief Exits After BP Takeover Proposal Rejected
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Robinhood Expands Sports Event Contracts With Player Performance Wagers
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 



